Loading...
Gliclazide
India Pharmaceutical Trade Intelligence
Who Supplies Gliclazide to India from CANADA
India's gliclazide imports from CANADA total $1.1K across 13 shipments from 5 foreign suppliers. JAMP PHARMA CORPORATION leads with $572 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ACCUTEST RESEARCH LABORATORIES INDIA PRIVATE LIMIT. This corridor reflects India's pharmaceutical import demand for gliclazide — a diversified sourcing base with multiple active suppliers from CANADA.
Top foreign suppliers (CANADA) — Ranked by import value
JAMP PHARMA CORPORATION is the leading Gliclazide supplier from CANADA to India, with import value of $572 across 3 shipments. The top 5 suppliers — JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC,, Apotex Inc., APOTEX INC — collectively account for 100.0% of total import value from this origin.
Top foreign suppliers (CANADA)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | JAMP PHARMA CORPORATION | $572 | 3 | 52.5% |
| 2 | TEVA CANADA LIMITED | $206 | 2 | 18.9% |
| 3 | APOTEX INC, | $124 | 2 | 11.4% |
| 4 | Apotex Inc. | $118 | 2 | 10.8% |
| 5 | APOTEX INC | $69 | 4 | 6.3% |
Showing top 5 of 5 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from CANADA)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ACCUTEST RESEARCH LABORATORIES INDIA PRIVATE LIMIT | $328 | 1 | 30.1% |
| 2 | APOTEX RESEARCH PRIVATE LIMITED | $311 | 8 | 28.5% |
| 3 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $206 | 2 | 18.9% |
| 4 | LAMBDA THERAPEUTIC RESEARCH LIMITED | $175 | 1 | 16.0% |
| 5 | MEDREICH LIMITED | $70 | 1 | 6.4% |
Import Statistics
- Import Value
- $1.1K
- Shipments
- 13
- Foreign Suppliers
- 5
- Indian Buyers
- 5
- Avg. Shipment
- $84
Other Gliclazide Import Origins
Related Analysis
Frequently Asked Questions — Gliclazide Imports from CANADA
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Gliclazide suppliers from CANADA to India?
The top Gliclazide suppliers from CANADA to India include JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC,. The leading supplier is JAMP PHARMA CORPORATION with import value of $572 USD across 3 shipments. India imported Gliclazide worth $1.1K USD from CANADA in total across 13 shipments.
QHow much Gliclazide does India import from CANADA?
India imported Gliclazide worth $1.1K USD from CANADA across 13 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Gliclazide from CANADA?
The main Indian buyers of Gliclazide sourced from CANADA include ACCUTEST RESEARCH LABORATORIES INDIA PRIVATE LIMIT, APOTEX RESEARCH PRIVATE LIMITED, ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED. The largest buyer is ACCUTEST RESEARCH LABORATORIES INDIA PRIVATE LIMIT with $328 in imports across 1 shipments.
QWhat is the total value of Gliclazide imports from CANADA to India?
The total value of Gliclazide imports from CANADA to India is $1.1K USD, across 13 shipments and 5 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: CANADA to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Gliclazide.
- 2.Supplier/Buyer Matching: 5 foreign suppliers from CANADA and 5 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $1.1K aggregated from 13 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
13 Verified Shipments
5 suppliers, 5 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists